NK-Cell Leukemia Recruiting Phase 2 Trials for Blinatumomab (DB09052)

Also known as: Aggressive NK-cell leukemia / NK-cell leukaemia / Natural killer-cell leukemia / Natural killer-cell leukaemia / Aggressive NK cell leukemia

DBCOND0115144 (NK-Cell Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03849651TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic MalignanciesTreatment